DOI: http://dx.doi.org/10.18203/2349-3933.ijam20205053

Endometriosis a brief review: evaluation of crucial risk factors and current treatment regimes

Ashish Ashish, Kusum Kusum, Sangeeta Rai, Royana Singh

Abstract


Endometriosis is an estrogen-dependent chronic inflammatory disease associated with substantial morbidity, including dyspareunia, dysmenorrhea, pelvic pain, multiple surgery, and infertility. This disease has a high impact on both woman’s physical and mental wellbeing. The etiology of endometriosis is complex and multifactorial. The risk factors associated with the development of endometriosis include family history, menstrual and reproductive cycle, low body mass index (BMI), diet, alcohol uses, smoking, environmental factors, immune system, genetic factors and intrinsic abnormalities in the endometrium. There exist many theories on the initiation and propagation of different types of endometriotic lesions and consequent biological disturbances, of which the most common is the Sampson’s theory according to which the retrograde flow of menstrual blood is linked to the development of endometriosis. Endometriosis affected women have a higher risk than the general female population, for ovarian cancer, coronary heart disease (CHD), and other long-term disease risks as well for autoimmune and atopic disorders. Therefore it becomes a necessity for the clinician not only to attain right diagnosis but also follow up for the other associated disorders.  In this review, we have considered the crucial risk factors and biomarkers of the endometriosis as well as the possible pathogenesis towards the development of endometriosis and its prevention strategies. The currently available therapies for the control and treatment of endometriosis have also been elaborated.


Keywords


Endometriosis, Epidemiology, Infertility, Risk factors, Biomarkers, Genetic risk factor

Full Text:

PDF

References


D’Hooghe TM, Debrock S. Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons. Hum Reprod Update. 2002;8(1):84-8.

Kyama CM, Debrock S, Mwenda JM, D’Hooghe TM. Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol. 2003;1:123.

Ahn SH, Monsanto SP, Miller C, Singh SS, Thomas R, Tayade C. Pathophysiology and immune dysfunction in endometriosis. BioMed Res Int. 2015;12.

Klemmt PA, Starzinski-Powitz A. Molecular and Cellular Pathogenesis of Endometriosis. Curr Women Heal Rev. 2017;13(999):1-11.

Vassilopoulou L, Matalliotakis M, Zervou M, Matalliotaki C, Krithinakis K, Matalliotakis I, et al. Defining the genetic profile of endometriosis (Review). Exp Ther Med. 2019;50(8):61-71.

Eisenberg V, Weil C, Chodick G, Shalev V. Epidemiology of endometriosis: a large population-based database study from a healthcare provider with 2 million members. An Int J Obstet Gynaecol. 2018;125(1):55-62.

Taylor HS, Adamson GD, Diamond MP, Goldstein SR, Horne AW, Missmer SA, et al. An evidence-based approach to assessing surgical versus clinical diagnosis of symptomatic endometriosis. Int J Gynecol Obstet. 2018;142(2):131-42.

Zondervan KT, Becker CM, Koga K, Missmer SA, Taylor RN, Viganò P. Endometriosis. Nat Rev Dis Prim. 2018;4(1):9.

Endometriosis month: 25 million Indian women suffer from painful condition that’s difficult to treat. Available at: https://scroll.in/pulse/872166/im-trapped-in-the-prison-of-my-body-the-severe-chronic-pain-of-endometriosis. Accessed on 25 September 2020.

Koninckx PR, Ussia A, Adamyan L, Wattiez A. An endometriosis classification, designed to be validated. Gynecol Surg. 2011;8(1):1-6.

Mehedintu C, Plotogea MN, Ionescu S, Antonovici M. Endometriosis still a challenge. J Med Life. 2014;7(3):349-57.

Khine YM, Taniguchi F, Harada T. Clinical management of endometriosis-associated infertility. Reprod Med Biol. 2016;15(4):217-25.

Li X, Zeng C, Zhou YF, Yang HX, Shang J, Zhu SN, et al. Endometriosis fertility index for predicting pregnancy after endometriosis surgery. Chin Med J (Engl). 2017;130(16):1932-7.

Malinak LR, Buttram VC, Elias S, Simpson JL. Heritage aspects of endometriosis. II. Clinical characteristics of familial endometriosis. Am J Obstet Gynecol. 1980;137(3):332-7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/7377253. Accessed on 25 September 2020.

Moen MH, Magnus P. The familial risk of endometriosis. Acta Obstet Gynecol Scand. 1993;72(7):560-4.

Stefansson H, Geirsson RT, Steinthorsdottir V, Jonsson H, Manolescu A, Kong A, et al. Genetic factors contribute to the risk of developing endometriosis. Hum Reprod. 2002;17(3):555-9.

Fung JN, Montgomery GW. Genetics of endometriosis: State of the art on genetic risk factors for endometriosis. Clin Obstet Gynaecol. 2018;50:61-71.

Uno S, Zembutsu H, Hirasawa A, Takahashi A, Kubo M, Akahane T, et al. A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese. Nat Genet. 2010;42(8):707-10.

Zanatta A, Rocha AM, Carvalho FM, Pereira RMA, Taylor HS, Motta ELA, et al. The role of the Hoxa10/HOXA10 gene in the etiology of endometriosis and its related infertility: A review. J Assist Reprod Genet. 2010;27(12):701-10.

Matalliotakis M, Zervou MI, Matalliotaki C, Rahmioglu N, Koumantakis G, Kalogiannidis I, et al. The role of gene polymorphisms in endometriosis. Mol Med Rep. 2017;16(5):5881-6.

Wei M, Cheng Y, Bu H, Zhao Y, Zhao W. Length of menstrual cycle and risk of endometriosis a meta-analysis of 11 case-control studies. Medicine (United States). 2016;95:1.

Petraglia F, Bernardi M, Lazzeri L, Perelli F, Reis FM. Dysmenorrhea and related disorders. F1000Res. 2017;6:1.

Bravi F, Parazzini F, Cipriani S, Chiaffarino F, Ricci E, Chiantera V, et al. BMJ open tobacco smoking and risk of endometriosis: A systematic review and meta-analysis. BMJ Open. 2014;4:1.

Ferrero S, Anserini P, Remorgida V, Ragni N. Body mass index in endometriosis. Eur J Obstet Gynecol Reprod Biol. 2005;121(1):94-8.

Monteiro R, Teixeira D, Calhau C. Estrogen signaling in metabolic inflammation. Mediators Inflamm. 2014;1:1.

Harris HR, Eke AC, Chavarro JE, Missmer SA. Fruit and vegetable consumption and risk of endometriosis. Hum Reprod. 2018;33(4):715-27.

Savaris AL, Do Amaral VF. Nutrient intake, anthropometric data and correlations with the systemic antioxidant capacity of women with pelvic endometriosis. Eur J Obstet Gynecol Reprod Biol. 2011;158(2):314-8.

Ridley JH. The validity of Sampson’s theory of endometriosis. Am J Obstet Gynecol. 1961;82(4):777-82.

Dorien FO, Roskams T, Van Den Eynde K, Vanhie A, Peterse DP, Meuleman C, et al. The Presence of Endometrial Cells in Peritoneal Fluid of Women with and Without Endometriosis. Reprod Sci. 2017;24(2):242-51.

Herington JL, Bruner-Tran KL, Lucas JA, Osteen KG. Immune interactions in endometriosis. Expert Rev Clin Immunol. 2011;7(5):611-26.

Kyama CM, Debrock S, Mwenda JM, D’Hooghe TM. Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol. 2003;1:123.

Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019;20.

Shigesi N, Kvaskoff M, Kirtley S, Feng Q, Fang H, Knight JC, et al. The association between endometriosis and autoimmune diseases: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(4):486-503.

Nielsen NM, Jørgensen KT, Pedersen B V., Rostgaard K, Frisch M. The co-occurrence of endometriosis with multiple sclerosis, systemic lupus erythematosus and Sjögren syndrome. Hum Reprod. 2011;26(6):1555-9.

Gleicher N, El-Roeiy A, Confino E, Friberg J. Is endornetriosis an autoimmune disease? Obstet Gynecol. 1987;70(1):115-22.

Horne AW, Saunders PTK, Abokhrais IM, Hogg L. Top ten endometriosis research priorities in the UK and Ireland. Lancet. 2017;389:2191-2.

Petracco R, Dias ACDO, Taylor HS, Petracco Á, Badalotti M, Michelon JDR, et al. Evaluation of miR-135a/b expression in endometriosis lesions. Biomed Rep. 2019;11(4):181-7.

Fait T. Menopause hormone therapy: Latest developments and clinical practice. Drugs in Context. 2019;8:1.

Mehedintu C, Plotogea MN, Ionescu S, Antonovici M. Endometriosis still a challenge. J Med Life. 2014;7:349-57.

Galarneau G, Clementi C. Genome-wide association studies on endometriosis and endometriosis-related infertility. BioRxiv. 2018;10(2):1-15.

Nyholt DR, Low S-K, Anderson CA, Painter JN, Uno S, Morris AP, et al. Genome-wide association meta-analysis identifies new endometriosis risk loci. Nat Genet. 2012;44(12):1355-9.

Sapkota Y, Steinthorsdottir V, Morris AP, Fassbender A, Rahmioglu N, De Vivo I, et al. Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism. Nat Commun. 2017;8:15539.

Wu MH, Hsiao KY, Tsai SJ. Endometriosis and possible inflammation markers. Gynecol Minimally Invasive Ther. 2015;61-7.

Yland J, Mathyk B, Young SL. Steroid Hormones and Endometriosis. Curr Women Health Rev. 2018;14(2):117-26.

Vodolazkaia A, Yesilyurt BT, Kyama CM, Bokor A, Schols D, Huskens D, et al. Vascular endothelial growth factor pathway in endometriosis: Genetic variants and plasma biomarkers. Fertil Steril. 2016;105(4):988-96.

Witz CA. Cell adhesion molecules and endometriosis. Sem Reprod Med. 2003;21:173-81.

Egorova A, Petrosyan M, Maretina M, Balashova N, Polyanskih L, Baranov V, et al. Anti-angiogenic treatment of endometriosis via anti-VEGFA siRNA delivery by means of peptide-based carrier in a rat subcutaneous model. Gene Ther. 2018;25(8):548-55.

García Manero M, Olartecoechea B, Aubá M, Alcázar JL, López G. Angiogenesis and endometriosis. Revista de medicina de la Universidad de Navarra. 2009;53:8-13.

Schüring AN, Dahlhues B, Korte A, Kiesel L, Titze U, Heitkötter B, et al. The endometrial stem cell markers notch-1 and numb are associated with endometriosis. Reprod Biomed Online. 2018;36(3):294-301.

Rai S, Ashish, Kumari P, Singh A, Singh R. Correlation of follicle-stimulating hormone receptor gene Asn 680 Ser (rs6166) polymorphism with female infertility. J Fam Med Prim Care. 2019;8(10):3356-61.